Diagnosis and differential diagnosis 
Gonococcal culture
Prevention 
Dr Erica Stewart, Centenary Institute[/caption]
Chelsea Felkai, MPS[/caption]
Working with the nursing staff to understand when PRN (as required) chemical restraint might be used, and ensuring other options have been exhausted first, has shown the most reduction in how much psychotropic medications have been used so far. The numbers are relatively small, but to be honest, this is largely because the facility had great protocols to begin with.
Dr Natalie Soulsby FPS[/caption]
Associate Professor Luke Grzeskowiak[/caption]
Pharmacists: the secret ingredient in the quit smoking journey
Each year, approximately 15,500 Australian families face the grief and trauma of someone they love dying from a disease caused by smoking. In 2017,...
Pharmacists receive Governor-General’s Honours
On behalf of the pharmacy profession, PSA congratulates the Australian pharmacists recognised in today’s Governor-General’s honours.
How pharmacists can support patients with dementia
Nicola Sander MPS, a dementia support pharmacist in regional South Australia, will share her experience at PSA25 in August.
SSRIs for mild cognitive impairment to Alzheimer’s disease
Could selective serotonin reuptake inhibitors (SSRIs) help reduce the burden of Alzheimer’s disease and prevent decline from mild cognitive impairment?
An estimated 10% of people...
Why you can’t miss PSA21
With a diverse program of clinical, therapeutic and industry sessions for pharmacists in all practice settings, PSA21 will help grow your medicines expertise.
TGA changes continue to impact and sometimes baffle pharmacists
A number of recent decisions by the Therapeutic Goods Administration (TGA) are highly relevant to pharmacists in Australia. Firstly, the interim decision from the...
